Ruthenium-nitrite complex as pro-drug releases NO in a tissue and enzyme-dependent way

Nitric Oxide - Biology and Chemistry

Volumn 24, Issue 4, 2011, Pages 192-198

  Pereira, Amanda De C ^a   Ford, Peter C ^b   Da Silva, Roberto S ^a   Bendhack, Lusiane M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Guanylyl cyclase; Nitric oxide; Nitrite; NO donor; Vasodilatation

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRITE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PHOSPHODIESTERASE; POTASSIUM CHLORIDE; PRODRUG; RUTHENIUM COMPLEX; RUTHENIUM NITRITE COMPLEX; UNCLASSIFIED DRUG;

AMPEROMETRY; ANIMAL TISSUE; AORTA; ARTERY DILATATION; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; DRUG POTENCY; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TIME; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; GUANYLATE CYCLASE; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE DONORS; OXADIAZOLES; PHENYLEPHRINE; PHOSPHORIC DIESTER HYDROLASES; PRODRUGS; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RUTHENIUM COMPOUNDS; VASODILATION; VASODILATOR AGENTS;

RATTUS;

EID: 79956337563     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2011.03.001     Document Type: Article

References (48)

1. S. Moncada, R.M. Palmer, E.A. Higgs, Nitric oxide: physiology, Pathophysiol. Pharmacol. Pharmacol. Rev. 43 (1991) 109-142.
2. D.D. Rees, R.M. Palmer, S. Moncada, Role of endothelium derived nitric oxide in the regulation of blood pressure, Proc. Nat. Acad. Sci. USA 86 (1989) 3375-3378. (Pubitemid 19129614)
3. B.J. Whittle, Nitric oxide in physiology and pathology, Histochem. J. 27 (1995) 727-737.
4. S. Moncada, A. Higgs, The L-arginine-nitric oxide pathway, New Eng. J. Med. 329 (1993) 2002-2012.
5. C.E. Van Hove, C. Van der Donckt, A.G. Herman, H. Bult, P. Fransen, Vasodilator efficacy of nitric oxide depends on mechanisms of intracellular calcium mobilization in mouse aortic smooth muscle cells, Br. J. Pharmacol. 158 (2009) 920-930.
6. F. Plane, K.E. Wiley, J.Y. Jeremy, R.A. Cohen, C.J. Garland, Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery, Br. J. Pharmacol. 123 (1998) 1351-1358.
7. T.M. Lincoln, P. Komalavilas, T.L. Cornwell, Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase, Hypertension 23 (1994) 1141-1147.
8. + channel in vascular smooth muscle, Nature 368 (1994) 850-853.
9. M. Kelm, M. Feelisch, R. Spahr, H.M. Piper, E. Noack, J. Schrader, Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells, Biochem. Biophys. Res. Commun. 154 (1998) 236-244.
10. T.D. Carter, N. Bettache, D. Ogden, Potency and kinetics of nitric oxide-mediated vascular smooth muscle relaxation determined with flash photolysis of ruthenium nitrosyl chlorides, Br. J. Pharmacol. 122 (1997) 971-973.
11. D.D. Thomas, L.A. Ridnour, J.S. Isenberg, W. Flores-Santana, C.H. Switzer, S. Donzelli, P. Hussain, C. Vecoli, N. Paolocci, S. Ambs, C.A. Colton, C.C. Harris, D.D. Roberts, D.A. Wink, The chemical biology of nitric oxide: implications in cellular signaling, Free Radical Biol. Med. 45 (2008) 18-31.
12. D.A. Wink, I. Hanbauer, M.B. Grisham, F. Laval, R.W. Nims, J. Laval, J. Cook, R. Pacelli, J. Liebmann, M. Krishna, P.C. Ford, J.B. Mitchell, Chemical biology of nitric oxide: regulation and protective and toxic mechanisms, Curr. Top. Cell Regul. 34 (1996) 159-187.
13. F. Roncaroli, J.A. Olabe, R. Van Eldik, Kinetics and mechanism of the Interaction of nitric oxide with pentacyanoferrate(II). Formation and dissociation of [Fe(CN)5NO]3, Inorg. Chem. 42 (2003) 4179-4189.
14. J.N. Bates, M.T. Baker, R.Jr. Guerra, D.G. Harrison, Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required, Biochem. Pharmacol. 42 (1991) S157-S165.
15. P.R. Shafer, D.E. Wilcox, H. Kruszyna, R. Kruszyna, R.P. Smith, Decomposition and specific exchange of the trans-cyanide ligand on nitroprusside is facilitated by hemoglobin, Toxicol. Appl. Pharmacol. 99 (1989) 1-10. (Pubitemid 19149138)
16. W.P. Arnold, D.E. Longnecker, R.M. Epstein, Photodegradation of sodium nitroprusside: biologic activity and cyanide release, Anesthesiology 61 (1984) 254-260. (Pubitemid 14074621)
17. P.C. Ford, S. Wecksler, Photochemical reactions leading to NO and NOx generation, Coord. Chem. Rev. 249 (2005) 1382-1395. (Pubitemid 41078789)
18. T. Yamamoto, R.J. Bing, Nitric oxide donors, Proc. Soc. Exp. Biol. Med. 225 (2000) 200-206. (Pubitemid 32041500)
19. C.N. Lunardi, R.S. da Silva, L.M. Bendhack, New nitric oxide donors based on ruthenium complexes, Braz. J. Med. Biol. Res. 42 (2009) 87-93.
20. M.J. Rose, P.K. Mascharak, Photoactive ruthenium nitrosyls: effects of light and potential application as NO donors, Coord. Chem. Rev. 252 (2008) 2093-2114.
21. E. Tfouni, F.G. Doro, A.J. Gomes, R.S. da Silva, G. Metzker, P.G.Z. Benini, D.W. Franco, Immobilized ruthenium complexes and aspects of their reactivity, Coord. Chem. Rev. 254 (2010) 355-371.
22. E. Tfouni, M. Krieger, B.R. McGarvey, D.W. Franco, Structure, chemical and photochemical reactivity and biological activity of some ruthenium amine nitrosyl complexes, Coord. Chem. Rev. 236 (2003) 57-69.
23. J.O. Lundberg, E. Weitzberg, Nitrite reduction to nitric oxide in the vasculature, Am. J. Physiol. Heart Circ. Physiol. 295 (2008) H477-478.
24. K. Cosby, K.S. Partovik, J.H. Crawford, R.P. Patel, C.D. Reiter, S. Martyr, B.K. Yang, M.A. Waclawiw, G. Zalos, X. Xu, K.T. Huang, H. Shields, D.B. Kim-Shapiro, A.N. Schechter, R.O. Cannon 3rd, M.T. Gladwin, Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation, Nat. Med. 9 (2003) 1498-1505.
25. J.O. Lundberg, E.Weitzberg,M.T. Gladwin, The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics, Nat. Rev. Drug Discovery 7 (2008) 156-167.
26. M.T. Gladwin, A.N. Schechter, D.B. Kim-Shapiro, R.P. Patel, N. Hogg, S. Shiva, R.O. Cannon 3rd, M. Kelm, D.A. Wink, M.G. Espey, E.H. Oldfield, R.M. Pluta, B.A. Freeman, J.R. Lancaster Jr., M. Feelisch, J.O. Lundberg, The emerging biology of the nitrite anion, Nat. Chem. Biol. 1 (2005) 308-314.
27. M.T. Gladwin, D.B. Kim-Shapiro, The functional nitrite reductase activity of the heme-globins, Blood 112 (2008) 2636-2647.
28. W.F. Alzawahra, M.A. Talukder, X. Liu, A. Samouilov, J.L. Zweier, Heme proteins mediate the conversion of nitrite to nitric oxide in the vascular wall, Am. J. Physiol. Heart Circ. Physiol. 295 (2008) H499-508.
29. X.Y. Wang, P. Legzdins, J.S. Poon, C.C. Pang, Vasodilator effects of organotransition-metal nitrosyl complexes, novel nitric oxide donors, J. Cardiovasc. Pharmacol. 35 (2000) 73-77. (Pubitemid 30032896)
30. D. Bonaventura, F. de S Oliveira, V. Togniolo, A.C. Tedesco, R.S. da Silva, L.M. Bendhack, A macrocyclic nitrosyl ruthenium complex is a NO donor that induces rat aorta relaxation, Nitric Oxide 10 (2004) 83-91. (Pubitemid 38591617)
31. C.N. Lunardi, A.L. Cacciari, R.S. Silva, L.M. Bendhack, Cytosolic calcium concentration is reduced by photolysis of a nitrosyl ruthenium complex in vascular smooth muscle cells, Nitric Oxide 15 (2006) 252-258. (Pubitemid 44466429)
32. D. Bonaventura, R.G. de Lima, J.A. Vercesi, R.S. da Silva, L.M. Bendhack, Comparison of the mechanisms underlying the relaxation induced by two nitric oxide donors: sodium nitroprusside and a new ruthenium complex, Vasc. Pharmacol. 46 (2007) 215-222.
33. M.G. Sauaia, R.S. Da Silva, The reactivity of nitrosyl ruthenium complexes containing polypyridyl ligands, Trans. Met. Chem. 28 (2003) 254-259.
34. D.A. Wink, J.F. Darbyshire, R.W. Nims, J.E. Saavedra, P.C. Ford, Reactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: determination of the kinetics for oxidation and nitrosation by intermediates generated in the NO/O2 reaction, Chem. Res. Toxicol. 6 (1993) 23-27. (Pubitemid 23040367)
35. S. Kudo, J.L. Bourassa, S.E. Boggs, Y. Sato, P.C. Ford, In situ nitric oxide (NO) measurement by modified electrodes: NO labialized by photolysis of metal nitrosyl complexes, Anal Biochem. 247 (1997) 193-202.
36. V. Mori, M. Bertotti, Nitric oxide solutions: standardization by chronoamperometry using a platinum disc microelectrode, Analyst 1251 (2000) 1629-1632.
37. H. Kojima, N. Nakatsubo, K. Kikuchi, Y. Urano, T. Higuchi, J. Tanaka, Y. Kudo, T. Nagano, Direct evidence of NO production in rat hippocampus and cortex using a new fluorescent indicator: DAF-2 DA, Neuroreport 9 (1998) 3345-3348. (Pubitemid 28566108)
38. M.G. Gomes, C.U. Davanzo, S.C. Silva, L.G.F. Lopes, P.S. Santos, D.W. Franco, Cis-and-trans-nitrosyltetraammineruthenium(II). Spectral and electrochemical properties and reactivity, J. Chem. Soc. Dalton Trans. (1998) 601-607. (Pubitemid 128786720)
39. F. Roncaroli, M.E. Ruggiero, D.W. Franco, G.L. Estiu, J.A. Olabe, Kinetic, mechanistic and DFT study of the electrophilic reactions of nitrosyl complexes with hydroxide, Inorg. Chem. 41 (2002) 5760-5769.
40. Z.N. da Rocha, M.S. Marchesi, J.C. Molin, C.N. Lunardi, K.M. Miranda, L.M. Bendhack, et al., The inducing NO-vasodilation by chemical reduction of coordinated nitrite ion in cis-[Ru(NO(2))L(bpy)(2)](+) complex, Dalton Trans. (2008) 4282-4287.
41. N. Nakatsubo, H. Kojima, K. Kikuchi, H. Nagoshi, Y. Hirata, D. Maeda, Y. Imai, T. Irimura, T. Nagano, Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: diaminofluoresceins, FEBS Lett. 427 (1998) 263-266. (Pubitemid 28225070)
42. J.G. Lopez-Lopez, F. Perez-Vizcaino, A.L. Cogolludo, M. Ibarra, F. Zaragoza-Arnaez, J. Tamargo, Nitric oxide- and nitric oxide donors-induced relaxation and its modulation by oxidative stress in piglet pulmonary arteries, Br. J. Pharmacol. 133 (2001) 615-624.
43. B.P. Bean, M. Sturek, A. Puga, K. Hermsmeyer, Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs, Circ. Res. 59 (1986) 229-235.
44. U. Walter, Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system, Rev. Physiol. Biochem. Pharmacol. 113 (1989) 41-88.
45. P.F. Mery, S.M. Lohmann, U. Walter, R. Fischmeister, Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes, Proc. Nat. Acad. Sci. USA 88 (1991) 1197-1201. (Pubitemid 21916192)
46. J. Garthwaite, E. Southam, C.L. Boulton, E.B. Nielsen, K. Schmidt, B. Mayer, Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, Mol. Pharmacol. 48 (1995) 184-188.
47. M. Feelisch, P. Kotsonis, J. Siebe, B. Clement, H.H. Schmidt, The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation, Mol. Pharmacol. 56 (1999) 243-253.
48. A. Gamboa, R. Abraham, A. Diedrich, C. Shibao, Y. Sachin, B.S. Paranjape, G. Farley, I. Biaggioni, Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole, Stroke 36 (2005) 2170-2175. (Pubitemid 41429240)